Published in

American Heart Association, Circulation Research, 8(118), p. 1327-1336, 2016

DOI: 10.1161/circresaha.116.307709

Links

Tools

Export citation

Search in Google Scholar

Brain–Gut–Bone Marrow Axis

Journal article published in 2016 by Monica M. Santisteban ORCID, Seungbum Kim, Carl J. Pepine ORCID, Mohan K. Raizada
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Hypertension is the most prevalent modifiable risk factor for cardiovascular disease and disorders directly influencing cardiovascular disease morbidity and mortality, such as diabetes mellitus, chronic kidney disease, obstructive sleep apnea, etc. Despite aggressive attempts to influence lifestyle modifications and advances in pharmacotherapeutics, a large percentage of patients still do not achieve recommended blood pressure control worldwide. Thus, we think that mechanism-based novel strategies should be considered to significantly improve control and management of hypertension. The overall objective of this review is to summarize implications of peripheral- and neuroinflammation as well as the autonomic nervous system–bone marrow communication in hematopoietic cell homeostasis and their impact on hypertension pathophysiology. In addition, we discuss the novel and emerging field of intestinal microbiota and roles of gut permeability and dysbiosis in cardiovascular disease and hypertension. Finally, we propose a brain–gut–bone marrow triangular interaction hypothesis and discuss its potential in the development of novel therapies for hypertension.